Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-039215
Filing Date
2022-02-14
Accepted
2022-02-14 06:40:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d313112dsc13ga.htm SC 13G/A 41725
  Complete submission text file 0001193125-22-039215.txt   43195
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 22624957
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON BOSTON MA 02116
Business Address 200 CLARENDON BOSTON MA 02116 6175162000
BCLS II Equity Opportunities, LP (Filed by) CIK: 0001814474 (see all company filings)

EIN.: 850698036 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A